Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Administration of Recombinant Erythropoietin (RHEPO) in Transfusion Savings in Trauma Patients

NCT03867071 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT03867071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03867071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Administration of Recombinant Erythropoietin (RHEPO) in Transfusion Savings in Trauma Patients
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2005
Completion date
July 31, 2012
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trauma